When the Medicine Must Also Heal the Planet

Pharmaceutical manufacturing carries a paradox: medicines preserve life while making them harms the environment. Sanofi, a €41 billion French drugmaker with 83,000 employees, treats this as an engineering problem through its SBTi-validated Planet Care roadmap.

Sanofi built four structural mechanisms: the modular Modulus biomanufacturing platform, geography-by-geography renewable power contracts, an employee-funded Planet Care Challenge, and an eco-design tool that models environmental cost from raw material to patient excretion.

By 2024, Sanofi cut Scope 1 and 2 emissions 47% against its 2019 baseline and reached 85% renewable electricity, while eco-design redesigns cut Cerezyme's climate impact 80% and Toujeo's by 50%, versus earlier product versions.

Modulus was named a TIME Best Invention of 2025, but the deeper lesson is mechanical: PPA contracting and life-cycle eco-design are documented, replicable methods any high-emission industry facing similar regulatory constraints can adapt.